Non-Invasive Positive Pressure Ventilation (CPAP & BiPAP) | Lecture 6

Added:

The Danger of Delayed Intubation and Patient-Self-Induced Lung Injury (P-SILI)

While Non-Invasive Positive Pressure Ventilation (NPPV) is highly effective for hypercapnic respiratory failure (such as COPD exacerbations) and cardiogenic pulmonary edema, its use in de novo hypoxemic respiratory failure (like ARDS or severe pneumonia) is highly controversial. A major clinical counter-perspective warns that relying too long on CPAP or BiPAP can mask worsening respiratory failure and delay necessary endotracheal intubation, a delay strongly associated with increased mortality. Furthermore, strong spontaneous breathing efforts during NPPV can generate excessive transpulmonary pressures, leading to Patient-Self-Induced Lung Injury (P-SILI). Consequently, many experts advocate for early invasive ventilation or the alternative use of High-Flow Nasal Cannula (HFNC) therapy, which may offer safer, more comfortable oxygenation without the high pressure-related risks of NPPV.

Basic respiratory anatomy and physiology, particularly the mechanics of normal breathing (negative pressure ventilation) and gas exchange.
The classification and pathophysiology of acute respiratory failure, distinguishing between Type 1 (hypoxemic) and Type 2 (hypercapnic) failure.
Arterial Blood Gas (ABG) interpretation, including how to identify respiratory acidosis, hypoxia, and compensatory mechanisms.
Initial clinical assessment of respiratory distress, including monitoring vital signs, work of breathing, and mental status.
Indications, preparation, and protocols for invasive mechanical ventilation and endotracheal intubation when NPPV fails.
Advanced troubleshooting of non-invasive ventilation, including managing mask leaks, patient-ventilator asynchrony, and skin breakdown.
Weaning strategies from NPPV and transitioning patients safely to high-flow nasal cannula (HFNC) or conventional oxygen therapy.
Management guidelines for specific disease states commonly treated with NPPV, such as COPD exacerbations, acute cardiogenic pulmonary edema, and sleep apnea.
274.4K views2Klikes17:43@StrongMedOriginal Release: 2011-11-21

Non-invasive positive pressure ventilation (NPPV) delivers oxygen-rich gas under pressure without endotracheal intubation, offering benefits such as avoiding intubation trauma, reducing ventilator-associated pneumonia risk, and preserving patient communication and eating abilities; it includes two primary modes—CPAP (Continuous Positive Airway Pressure) which applies a single continuous pressure throughout both breathing phases to improve oxygenation in hypoxic respiratory failure, and BiPAP (Bilevel Positive Airway Pressure) which provides two different pressure levels (higher during inspiration, lower during expiration) to address both ventilation and oxygenation in hypercapnic or mixed respiratory failure—with CPAP typically starting at 5 cm H2O and BiPAP at 10/5 cm H2O, both titrated upward based on patient tolerance and clinical response.